LVMH Moet Hennessy Louis Vuitton (ETR:MOH) Stock Upgrade
LVMH Moet Hennessy Louis Vuitton (ETR:MOH) was just upgraded by Societe Generale to a respectable Buy rating in analysts note issued to clients and investors on Saturday morning. The firm now has a EUR 177.00 price target on the shares. This target is 21.73% from MOH’s current share price.
From a total of 13 analysts covering LVMH Moet Hennessy Louis Vuitton (ETR:MOH) stock, 7 rate it a ”Buy”, 0 a “Sell”, and 7 a ”Hold”. This means that 50% of the ratings are positive. The highest target price is €105 while the lowest target price is €65. The mean of all analyst targets is €84.62 with a 207.08% above today’s (€57.95) stock price. LVMH Moet Hennessy Louis Vuitton was the topic of 8 analyst reports since July 22, 2015 according to the firm StockzIntelligence Inc. Citigroup upgraded shares on October 14 to “Buy” rating. Nomura maintained shares with “Neutral” rating and €175 target share price in a report from a July 29. Goldman Sachs maintained MOH stock in a recent report from September 8 with “Neutral” rating. Independent Research upgraded the rating on July 22. Independent Research has a “Buy” rating and a €198 price target on shares. Finally, Societe Generale maintained the stock with “Hold” rating in a report issued on a July 31.
The stock decreased 0.70% or EUR 0.41 during the last trading session, striking EUR 57.95. Approximately 1.19 million shares of stock traded hands or 22.26% up from the average. Molina Healthcare, Inc. (ETR:MOH) has declined 10.38% since May 8, 2015 and is downtrending. It has underperformed by 7.36% the S&P500.
The overall sentiment of institutions has decreased to 1.58 in Q2 2015. Its down 0.80, from 2.38 in 2015Q2. The ratio fall, as 31 institutions have sold all the shares of Molina Healthcare, Inc. that they owned while 80 funds have taken shares off the table. 55 funds have purchased shares for the first time while 120 added to their positions. These institutions now hold 45.35 million shares or 1.54% less than the 46.06 million shares they owned in 2015Q2.
The Fund Credit Capital Investments Llc currently is holding shares equating to 4.95% of its total portfolio in Molina Healthcare, Inc. representing a total of 107,147 shares. Another fund,Metropolitan Capital Advisors Inc, is holding a total of 60,200 shares equating to 3.81% of their holdings. Additionally, Orbimed Advisors Llc has a 3.24 million share stake in Molina Healthcare, Inc. which represents 2.25% of their total portfolio. The Fund, Ct Mason, based out of Massachusetts, has also built up a stake in the stock, which represents a total of 2.06% of their total portfolio. Finally Falcon Point Capital Llc, a fund which is based in the state of California reported a total holdings of 81,126 shares.
Insider activity is a very important aspect to track on any stock. Going back to March 5, 2015, shareholders of Molina Healthcare, Inc. have witnessed 0 insider buys, and a total of 19 insider sales equating to a net activity of approximately $11.65 million . Romney Ronna sold 250 shares worth approximately $16,443. Molina J Mario Md sold 20,000 shares worth approximately $1.37 million. Molina John C sold 15,933 shares worth approximately $1.25 million. Orlando Steven J sold 2,500 shares worth approximately $196,500. The company insider Bayer Terry sold 11,433 shares worth $932,878.
Molina Healthcare, Inc. provides health care to those receiving Government assistance. The company has a market cap of $3.27 billion. The Firm offers Medicaid-related solutions for low-income families and individuals, and assists state agencies in their administration of the Medicaid program. It has 20.7 P/E ratio. The Firm operates through two divisions: Health Plans segment and Molina Medicaid Solutions segment.
According to Zacks Investment Research, “Molina Healthcare is a multi-state managed care organization that arranges for the delivery of healthcare services to persons eligible for Medicaid and other programs for low-income families and individuals. It currently operates health plans in California, Washington, Michigan and Utah.” Get a free copy of the Zacks research report on Molina Healthcare, Inc. (MOH).